Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrooks Macdonald Regulatory News (BRK)

Share Price Information for Brooks Macdonald (BRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,130.00
Bid: 2,010.00
Ask: 2,130.00
Change: 20.00 (0.98%)
Spread: 120.00 (5.97%)
Open: 2,050.00
High: 2,140.00
Low: 2,050.00
Prev. Close: 2,050.00
BRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director appointment

16 Feb 2023 07:00

RNS Number : 0700Q
Brooks Macdonald Group PLC
16 February 2023
 

16 February 2023

 

BROOKS MACDONALD GROUP PLC

 

Director appointment

 

Brooks Macdonald Group plc ("The Group", "Brooks Macdonald") is pleased to announce the appointment of James Rawlingson as Non-Executive Director effective 2 March 2023. James will in due course assume the role of Chairman of the Audit Committee, subject to regulatory approval.

 

James currently serves as Chairman of the Audit and Risk Committee at Citibank UK, Chairman of the Audit and Risk Assurance Committee at the Foreign Office's executive agency Wilton Park, and Chairman of the Board at Novai Ltd. In his executive career James has held senior positions at Coutts, UBS Wealth, Charles Stanley plc and Arix Bioscience plc.

 

Commenting on the appointment, Acting Chairman Richard Price said: "I am delighted that James is joining the Board. James has had an extensive career and his sector experience will provide valuable insight as the Company continues towards its strategic goals."

 

AIM disclosures

 

During the five years immediately preceding the date of this announcement, James Hedley Rawlingson, who is 55 years old, held the following directorships:

 

Current

 

Citibank UK Limited

Wilton Park (an Arm's Length Body of the British Foreign, Commonwealth & Development Office)

Novai Limited

 

Previous

 

Next Gen PPE limited

Arix Bioscience Holdings Limited

Arix Bioscience plc

Arthurian Life Sciences GP Limited

Als SPV Limited

Arix Capital Management Limited

Arthurian Life Sciences SPV GP Limited

 

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

 

Enquiries to:

Brooks Macdonald Group plc

Andrew Shepherd, CEO

www.brooksmacdonald.com

020 7927 4816

 

Peel Hunt LLP (Nominated Adviser and Broker)

Paul Shackleton / Andrew Buchanan / John Welch

020 7418 8900

 

FTI Consulting

Laura Ewart / Katherine Bell

brooksmacdonald@fticonsulting.com

07711 387 085 / 07976 870 961

 

Notes to editors

 

Brooks Macdonald Group plc, through its various subsidiaries, provides leading investment management services in the UK and internationally. The Group, which was founded in 1991 and began trading on AIM in 2005, had discretionary Funds under Management of £16.2 billion as at 31 December 2022.

 

Brooks Macdonald offers a range of investment management services to private high net worth individuals, pension funds, institutions, charities and trusts. The Group also provides financial planning as well as international investment management, and acts as fund manager to a range of onshore and international funds.

 

The Group has fifteen offices across the UK and Crown Dependencies including London, Birmingham, Cheltenham, East Anglia, Exeter, Leeds, Manchester, Nuneaton, Southampton, Tunbridge Wells, Scotland, Wales, Jersey, Guernsey and Isle of Man.

 

LEI: 213800WRDF8LB8MIEX37

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVSWROAUUAAR
Date   Source Headline
25th May 20184:44 pmRNSHolding(s) in Company
25th May 20184:06 pmRNSDirectorate Change
24th May 20184:02 pmRNSDirector/PDMR Shareholding
23rd May 20184:24 pmRNSExercise of Options and EBT dealings
22nd May 20189:26 amRNSDirector/PDMR Shareholding
17th May 20181:26 pmRNSEmployee Benefit Trust Dealings
11th May 20183:17 pmRNSExercise of Options and EBT dealings
27th Apr 20187:00 amRNSQuarterly Announcement of Funds under Management
25th Apr 20183:08 pmRNSEmployee Benefit Trust Dealings
13th Apr 20181:02 pmRNSDirector/PDMR Shareholding
12th Apr 20181:47 pmRNSCORRECTION Director/PDMR Shareholding
12th Apr 20187:00 amRNSDirector/PDMR Shareholding
5th Apr 20183:50 pmRNSExercise of Options
4th Apr 20185:21 pmRNSExercise of Options and EBT dealings
27th Mar 201811:42 amRNSDirector / PDMR Shareholding
23rd Mar 20185:53 pmRNSDirector / PDMR Shareholding
22nd Mar 20182:48 pmRNSEmployee Dealings
13th Mar 20187:00 amRNSHalf-year Report
8th Mar 20189:20 amRNSEmployee Benefit Trust Dealings
21st Feb 20187:00 amRNSDirectorate Change
20th Feb 201810:45 amRNSEmployee Benefit Trust Dealings
9th Feb 20183:44 pmRNSExercise of Options
24th Jan 20187:00 amRNSTrading Update
16th Jan 201812:42 pmRNSDirector / PDMR Shareholding
8th Jan 201812:10 pmRNSSecond Price Monitoring Extn
8th Jan 201812:04 pmRNSPrice Monitoring Extension
5th Jan 20182:27 pmRNSHolding(s) in Company
27th Dec 201711:45 amRNSExercise of Options
5th Dec 20177:00 amRNSDirectorate Change
1st Dec 201710:35 amRNSExercise of Options
28th Nov 20175:00 pmRNSExercise of Options
22nd Nov 201712:33 pmRNSExercise of Options
15th Nov 201710:30 amRNSExercise of Options
8th Nov 20175:58 pmRNSDirector/PDMR Shareholding
3rd Nov 20177:00 amRNSDirector/PDMR Shareholding
24th Oct 20176:17 pmRNSResult of AGM
24th Oct 20177:00 amRNSQuarterly Announcement of Funds under Management
12th Oct 20174:58 pmRNSExercise of Options
10th Oct 20172:22 pmRNSExercise of Options
28th Sep 20174:51 pmRNSExercise of Options and PDMR Dealings
26th Sep 20174:54 pmRNSExercise of Options
21st Sep 20177:00 amRNSDisposal
21st Sep 20177:00 amRNSFinal Results
12th Sep 20174:40 pmRNSSecond Price Monitoring Extn
12th Sep 20174:35 pmRNSPrice Monitoring Extension
24th Aug 20174:08 pmRNSDirector/PDMR Shareholding
17th Aug 20179:25 amRNSHolding(s) in Company
15th Aug 20175:47 pmRNSDirector/PDMR Shareholding
9th Aug 20172:54 pmRNSExercise of Options
27th Jul 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.